(Q35918730)

English

Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease

scientific article published in November 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease (English)

1 reference

Europe PubMed Central

11 August 2017

venous thromboembolism

1 reference

based on heuristic

inferred from title

Hormone Replacement Therapy

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Lowe GD

1

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

11 August 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

11 August 2017

256

1 reference

Europe PubMed Central

11 August 2017

5

1 reference

Europe PubMed Central

11 August 2017

361-374

1 reference

Europe PubMed Central

11 August 2017

The primary prevention of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Myth and paradox of coronary risk and the menopause

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Role of endogenous oestrogen in aetiology of coronary heart disease: analysis of age related trends in coronary heart disease and breast cancer in England and Wales and Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Evidence from randomised trials on the long-term effects of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Venous thrombosis: a multicausal disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Estrogen plus progestin and the risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Understanding the divergent data on postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Hemostatic and rheological variables and risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Prospective study of exogenous hormones and risk of pulmonary embolism in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01400.X

21 January 2018

Identifiers

10.1111/J.1365-2796.2004.01400.X

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35918730&oldid=1629984910"